BCI
PACB icon

Brinker Capital Investments’s Pacific Biosciences PACB Stock Holding History

Brinker Capital Investments’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,953
Closed -$153K – 1733
2023
Q4 		$153K Buy
+19,953
New +$163K ﹤0.01% 1604

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Brinker Capital Investments's PACB Position: Q1 2024 in Review

Brinker Capital Investments sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 19,953 shares — an estimated $153K sold.

Brinker Capital Investments first reported a position in PACB in Q4 2023 and held it in 1 quarter. The position peaked at $153K in Q4 2023. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • Brinker Capital Investments reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
  • Brinker Capital Investments sold 19,953 Pacific Biosciences shares in Q1 2024, an estimated $153K.
  • Brinker Capital Investments first reported a position in Pacific Biosciences in Q4 2023 and held it in 1 quarter.
  • Brinker Capital Investments's Pacific Biosciences position peaked at $153K in Q4 2023.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Brinker Capital Investments's 13F filing for Q1 2024, filed 31 Jul 2025.